Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Dr. Khurram JamilChief Medical Officer | -568,00 | 1,06k | Derivative Exercise and Sale | 1,23 - 3,10 | 0,00 | - |
| 2026-02-06 | Mr. Kary EldredIndependent Director | 300,00 | 810,00 | Acquisto | 2,70 | 501,63k | 0,06% |
| 2026-01-05 | Mr. Joel LewisPresident & CEO | -56,33k | 218,57k | Sale to Issuer | 3,88 | 778,26k | -6,75% |
| 2026-01-02 | Mr. Joel LewisPresident & CEO | -84,00k | 321,13k | Derivative Exercise and Sale | 3,58 - 4,20 | 834,59k | - |
| 2026-01-02 | Dr. Khurram JamilChief Medical Officer | -60,00k | 232,40k | Derivative Exercise and Sale | 3,65 - 4,20 | 0,00 | - |
| 2026-01-02 | Mr. Jack W. CallicuttCFO, Treasurer & Corporate Secretary | -60,00k | 233,39k | Derivative Exercise and Sale | 3,67 - 4,20 | 7,61k | - |
| 2025-12-31 | Dr. Khurram JamilChief Medical Officer | -8,13k | 23,10k | Derivative Exercise and Sale | 1,23 - 4,07 | 0,00 | - |
| 2025-12-23 | Mr. Kevin D. FreemanIndependent Vice Chair of the Board | 5,50k | 19,51k | Acquisto | 3,55 | 153,33k | 3,72% |
| 2025-12-23 | Mr. Kary EldredIndependent Director | 700,00 | 2,61k | Acquisto | 3,73 | 501,33k | 0,14% |
| 2025-12-17 | Mr. Joel LewisPresident & CEO | -7,83k | 32,85k | Derivative Exercise and Sale | 2,86 - 7,06 | 834,59k | - |
| 2025-12-17 | Dr. Khurram JamilChief Medical Officer | -14,96k | 69,87k | Derivative Exercise and Sale | 2,20 - 7,04 | 0,00 | - |
| 2025-12-17 | Dr. Khurram JamilChief Medical Officer | -4,48k | 31,53k | Automatic Disposition | 7,04 | 0,00 | -100,00% |
| 2025-12-17 | Dr. Harold H. ShlevinDirector | -20,00k | 101,16k | Derivative Exercise and Sale | 1,98 - 7,04 | 6,50k | - |
| 2025-12-17 | Dr. Harold H. ShlevinDirector | -4,50k | 31,66k | Automatic Disposition | 7,04 | 6,50k | -40,90% |
| 2025-12-16 | 10x Capital Management, LLCSocietà | -30,68k | 204,34k | Vendita | 6,66 | 5,61M | -0,54% |
| 2025-11-24 | 10x Capital Management, LLCSocietà | -24,00k | 0,00 | Other Disposition | - | 5,61M | -0,43% |
| 2025-12-12 | Dr. Harold H. ShlevinDirector | -28,21k | 59,85k | Derivative Exercise and Sale | 4,16 - 6,30 | 11,21k | - |
| 2025-12-08 | Dr. Harold H. ShlevinDirector | -171,79k | 640,49k | Derivative Exercise and Sale | 1,11 - 6,27 | 11,21k | - |
| 2025-12-08 | Dr. Harold H. ShlevinDirector | -4,00k | 24,02k | Automatic Disposition | 6,01 | 11,21k | -26,31% |
| 2025-12-02 | 10x Capital Management, LLCSocietà | -162,07k | 920,86k | Vendita | 5,47 - 5,73 | 5,67M | -2,78% |
| 2025-11-17 | Mr. Jack W. CallicuttCFO, Treasurer & Corporate Secretary | -77,92k | 359,29k | Derivative Exercise and Sale | 1,11 - 6,22 | 7,61k | - |
| 2025-11-17 | Mr. Joel LewisPresident & CEO | -22,46k | 82,68k | Derivative Exercise and Sale | 2,39 - 6,15 | 834,59k | - |
| 2025-11-13 | Dr. Khurram JamilChief Medical Officer | -99,25k | 327,86k | Derivative Exercise and Sale | 1,23 - 5,47 | 4,48k | - |
| 2025-11-13 | Dr. Khurram JamilChief Medical Officer | -21,87k | 119,61k | Automatic Disposition | 5,47 | 4,48k | -83,00% |
| 2025-11-11 | 10x Capital Management, LLCSocietà | -40,00k | 210,00k | Vendita | 5,25 | 5,83M | -0,68% |
| 2025-11-10 | Mr. Joel LewisPresident & CEO | -1,87k | 6,79k | Derivative Exercise and Sale | 2,39 - 6,03 | 834,59k | - |
| 2025-11-05 | Mr. Joel LewisPresident & CEO | -200,00 | 722,00 | Derivative Exercise and Sale | 2,39 - 6,00 | 834,59k | - |
| 2025-11-03 | Mr. Joel LewisPresident & CEO | -15,72k | 57,77k | Derivative Exercise and Sale | 2,39 - 6,07 | 834,59k | - |
| 2025-10-22 | 10x Capital Management, LLCSocietà | -50,00k | 246,80k | Vendita | 4,93 - 4,94 | 5,87M | -0,84% |
| 2024-04-22 | 10x Capital Management, LLCSocietà | -25,00k | 76,50k | Vendita | 3,06 | 5,92M | -0,42% |
| 2025-09-12 | Mr. Joel LewisPresident & CEO | -14,00k | 55,59k | Derivative Exercise and Sale | 2,39 - 6,36 | 834,59k | - |
| 2025-09-12 | Mr. Jack W. CallicuttCFO, Treasurer & Corporate Secretary | -8,71k | 44,13k | Derivative Exercise and Sale | 1,37 - 6,44 | 7,61k | - |
| 2025-07-21 | Mr. Kary EldredIndependent Director | 1.000,00 | 2,93k | Acquisto | 2,93 | 500,63k | 0,20% |
| 2025-07-17 | Mr. Kevin D. FreemanIndependent Vice Chair of the Board | 5,00k | 14,50k | Acquisto | 2,90 | 147,83k | 3,50% |
| 2025-06-06 | Mr. James C. CzirrInsider | 323,13k | 699,34k | Derivative Exercise and Retained Stock | 0,89 - 4,72 | 1,05M | 44,73% |
| 2025-02-03 | Mr. James C. CzirrInsider | -20,00k | 0,00 | Other Disposition | - | 1,05M | -1,88% |
| 2024-05-10 | Mr. James C. CzirrInsider | -23,20k | 0,00 | Other Disposition | - | 741,42k | -3,03% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
